Research
SALSI awards $200,000 for brain health research initiatives
July 27, 2016
The San Antonio Life Sciences Institute (SALSI) recently awarded $200,000 through its “Clusters in Research Excellence: Brain Health” to researchers at the Health Science Center and UTSA to advance research in brain health.
The Doctor Is In: The power of exercise
July 25, 2016
Stacey Young-McCaughan, RN, Ph.D., professor, Division of Behavioral Medicine, studies the benefits of running coupled with prolonged exposure therapy to treat PTSD. Her research has also involved the benefits of exercise for cancer patients.
Science Daily: Brain cell death in Alzheimer’s linked to structural flaw
July 14, 2016
Researchers found that the nuclei from brain cells of patients with Alzheimer’s disease contained tunnels (arrows) not found in normal brain cells. “We have identified multiple new cellular processes that go awry in Alzheimer’s disease because of pathological tau,” said Bess Frost, Ph.D., assistant professor, Barshop Institute for Longevity and Aging Studies.
UT System among top universities for patents granted
July 13, 2016
Researchers at institutions within The University of Texas System, including a faculty member at the Health Science Center, have earned UT a spot among the world’s top universities that receive U.S. patents for breakthroughs in medicine and technology.
U.S. News & World Report: This old drug could boost your memory
July 5, 2016
A long-used drug called methylene blue may rev up activity in brain regions involved in short-term memory and attention, a small study suggests. Methylene blue has been used in medicine for more than a century, said Timothy Duong, the senior researcher on the study and a professor at the University of Texas Health Science Center at San Antonio.
Advancements in new hepatitis C treatments
June 3, 2016
Hepatitis C is the leading blood-borne disease in the U.S., with more than 3.5 million people developing a chronic infection. While the outlook for treating hepatitis C was grim just a few years ago, now most patients can be cured with direct-acting antiviral medications, many of them evaluated at the UT Health Science Center San Antonio.